Navigation Links
Oncolytics Biotech(R) Inc. Announces Second Quarter 2010 Results
Date:7/29/2010

--------------------------

To view the Company's Second Quarter 2010 Consolidated Financial Statements, related Notes to Consolidated Financial Statements, and Management's Discussion and Analysis, please see the Company's quarterly filings which will be available on www.sedar.com and on www.oncolyticsbiotech.com.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of human trials including a Phase III trial in head and neck cancers using REOLYSIN, its proprietary formulation of the human reovirus. For further information about Oncolytics, please visit: www.oncolyticsbiotech.com.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the Company's belief as to the potential of REOLYSIN as a cancer therapeutic; the Company's expectations as to the success of its research and development programs in 2010 and beyond, the Company's planned operations, the value of the additional pa
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Oncolytics Biotech(R) Inc. Announces Issuance of 35th U.S. Patent
2. Oncolytics Biotech(R) Inc. To Host Conference Call to Discuss Updated U.K. Phase I/II Trial Head and Neck Cancer Data Being Presented at the ASCO Annual Meeting
3. Oncolytics Biotech(R) Inc. Receives Approval from Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
4. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Pancreatic Cancer Clinical Trial
5. Oncolytics Biotech(R) Inc. Announces Opening of Enrollment in Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
6. Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at ASCO Annual Meeting
7. Oncolytics Biotech(R) Inc. Announces Phase I Colorectal Cancer Study
8. Oncolytics Biotech(R) Inc. Announces Publication of Phase I Clinical Trial Results in Clinical Cancer Research
9. Oncolytics Biotech(R) Inc. Announces First Quarter 2010 Results
10. Oncolytics Biotech(R) Inc. Announces Details of 2010 Annual Shareholder Meeting
11. Oncolytics Biotech(R) Inc. Completes Patient Enrollment in Phase I Portion of U.S. Phase I/II Recurrent Malignant Gliomas Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... WASHINGTON, D.C., September 23, 2014Researchers from the University ... demonstrated a new method to improve the reliability ... carbon nanotubes (CNT), a semiconductor material that has ... the most promising successors to silicon for smaller, ... in a new paper published in the journal ...
(Date:9/23/2014)... of researchers from the University of Southampton,s Optoelectronics ... to fabricate a potential challenger to graphene. , ... a honeycomb lattice, is increasingly being used in ... switches and light sources, thanks to the unprecedented ... thermal conductivity and mechanically stretchable yet harder than ...
(Date:9/23/2014)... potential uses as ferroelectrics, fast ion conductors, and ... a great deal of scientific interest on the ... , "The interfaces separating the different crystalline regions ... the material as a whole," said Pratik Dholabhai, ... project. "It is in the chemical makeup of ...
(Date:9/23/2014)... YORK , Sept. 23, 2014 ... part of the biomaterial family and are increasingly ... with body fluids and tissues without having a ... extensively used as tissue replacement and tissue repair ... from materials such as ceramics, glass, glass-ceramics, and ...
Breaking Biology Technology:Future flexible electronics based on carbon nanotubes 2Future flexible electronics based on carbon nanotubes 3Future flexible electronics based on carbon nanotubes 4Southampton scientists grow a new challenger to graphene 2Los Alamos researchers uncover properties in nanocomposite oxide ceramics for reactor fuel 2Global Bioactive Material Market 2014-2018 2
... , , ... ("China Pharma") (NYSE Amex: CPHI ), which develops,manufactures, and ... present at the Brean Murray, Carret & Co. 2009 China,Growth ... Broadway,hotel in New York. Management is scheduled to present ...
... , CRACKS AMAZON.COM BEST SELLER LIST IN SCIENCE ... top ten best selling science books , SEATTLE, Nov. 17 ... new book about the controversial theory of intelligent design made Amazon.com,s ... as the world marks 150 years since Charles Darwin published his ...
... , KVISTGARD, ... today that BARDA (Biomedical Advanced Research and,Development Authority) has ... of a freeze-dried version of its IMVAMUNE(R) smallpox vaccine,with ... The contract provides funds to ...
Cached Biology Technology:China Pharma Holdings, Inc. to Present at Brean Murray China Growth Conference 2Intelligent Design Book Delivers Blow to Darwin 2US Government Awards Contract to Bavarian Nordic for the Development of Freeze-Dried IMVAMUNE(R) Smallpox Vaccine 2US Government Awards Contract to Bavarian Nordic for the Development of Freeze-Dried IMVAMUNE(R) Smallpox Vaccine 3
(Date:9/23/2014)... Ill. Antarctic fishes that manufacture their own ... Ocean also suffer an unfortunate side effect, researchers ... their bodies resist melting even when temperatures warm. ... Proceedings of the National Academy of Sciences ... an undesirable consequence of the evolution of antifreeze ...
(Date:9/23/2014)... man has domesticated animals, selecting the best traits ... offer an intriguing animal to examine adaptation to ... of selected breeding and a wealth of livestock ... kind study that combined molecular and environmental data, ... for genes under environmental selection from domesticated sheep ...
(Date:9/23/2014)... an athlete,s moving body relies on an orchestrated response of ... intersecting planes literally the geometry of a critical ... more than just a footfall error at the root of ... or anterior cruciate ligament tear. In fact, size of ... knee joint and volume of the ACL combine to ...
Breaking Biology News(10 mins):Study: Antifreeze proteins in Antarctic fishes prevent freezing ... and melting 2Study: Antifreeze proteins in Antarctic fishes prevent freezing ... and melting 3Being sheepish about climate adaptation 2Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 2Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 3
... is allowing scientists to better understand the movement of cells ... microenvironment. In a recent article published in Disease Models ... colleagues used optimized methods of laser microscopy to track the ... cancer. As a tumor grows, it triggers ...
... Activity in Identity ... Management and Biometrics, FALLS CHURCH, Va., Sept. ... relocating the CSC Identity Labs headquarters from Camp,Hill, Pa., to Fairmont, ... alignment with the federal government,s presence in the,I-79 High Technology Corridor, ...
... FL (September 16, 2008)- A team of scientists headed by neuroscientist ... grant by the National Institute of Health (NIH), to develop a ... injury. Dr. Chiba, a professor at the University of Miami,s Department ... groundbreaking process to enhance synapse formation or nerve regeneration., ...
Cached Biology News:CSC Identity Labs Headquarters Relocates to West Virginia 2CSC Identity Labs Headquarters Relocates to West Virginia 3NIH EUREKA grant awarded to University of Miami scientist 2
... AmpliTaq DNA Polymerase is the most thoroughly ... a testimony to its overall utility and ... it ideal for PCR applications. , ... results. ,, AmpliTaq DNA Polymerase is ...
... DNA Polymerase is a versatile and easy-to ... PCR applications. GCpro Taq DNA Polymerase is ... E. coli, containing the DNA polymerase I ... a highly processive 5'-3' DNA polymerase activity. ...
Taq DNA Polymerase (cloned), 250 units. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzymes, Polymerases....
APO(a) EIA Sample Size: 25 l...
Biology Products: